SCHEMBL27613842

SCHEMBL27613842

COC(=O)CCNC(C)CC(=N)C(=O)OC(C)(C)C

nearest known ligand 0.35

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
▸ CA12 O43570 4/20 0.35
▸ CA14 Q9ULX7 4/20 0.35
▸ CA2 P00918 2/20 0.35
▸ CA1 P00915 1/20 0.35
▸ CA7 P43166 1/20 0.34
▸ CA9 Q16790 1/20 0.34
▸ TSHR P16473 2/20 0.33
▸ CYP2D6 P10635 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27613831 0.80 CYP2D6 (0.33) CA2CA1CA7CYP2D6
SCHEMBL27904017 0.77 CA1 (0.34) CA2CA1CA7CYP2D6
SCHEMBL27957672 0.77 CA1 (0.34) CA2CA1CA7CYP2D6
SCHEMBL27613836 0.77 MAOA (0.36) CA2CA1CA7CYP2D6
SCHEMBL21385406 0.76 TSHR (0.48) CA12CA14CA2CA7CA9
SCHEMBL27694092 0.76 CA1 (0.38) CA12CA14CA2CA1CA7
SCHEMBL27713999 0.76 CA1 (0.38) CA12CA14CA2CA1CA7
SCHEMBL27704747 0.74 KMT2A (0.40) —
SCHEMBL20593365 0.73 TSHR (0.45) CA12CA14CA7CA9TSHR
SCHEMBL20593368 0.73 TSHR (0.45) CA12CA14CA7CA9TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104031054-A Chemokine receptor antagonists and methods of use thereof MILLENNIUM PHARM INC 2014-09-10 — — CN disclosed
CN-1585772-B chemokine receptor antagonists and methods and uses thereof MILLENNIUM PHARM INC 2014-06-04 — — CN disclosed
CN-1911930-A Chemokine receptor anagonists, methods and use therefor MILLENNIUM PHARM INC (US) 2007-02-14 — — CN disclosed
CN-1585772-A Chemokine receptor antagonists and methods and uses thereof MILLENNIUM PHARM INC (US) 2005-02-23 — — CN disclosed
Send feedback